Papers

4

Total Citations

15

H-Index

3

About

Omid Rezayof is pioneering the intersection of robotics and tissue engineering, with a core focus on *in situ* bioprinting for regenerative medicine. His major contributions lie in developing autonomous surgical robotic systems capable of printing living tissues directly inside the body to treat volumetric muscle loss (VML) injuries—a condition where significant muscle tissue is destroyed. Rezayof’s work addresses a critical bottleneck in the field: the lack of quantitative precision and uniformity in existing handheld and robotic bioprinting approaches. His 2024 study, which has garnered 6 citations, introduced a novel framework for evaluating curved bioprinted constructs, providing the first rigorous quantitative analysis of print thickness and consistency. Expanding this work, he developed a fully autonomous *in situ* bioprinting surgical robot, demonstrating its potential to translate bioprinting from bench to bedside. Beyond soft tissue, Rezayof has also advanced robotic spinal surgery with his S³D framework, a spatial steerable drilling system for precise spinal fixation. With a growing citation record and a clear trajectory toward clinical translation, Rezayof is establishing himself as a key innovator in surgical robotics and tissue engineering.

Research Focus

Key Achievements

3
H-Index
4
Papers
15
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Quantitative Evaluation of Curved BioPrinted Constructs of an <i>in Situ</i> Robotic System Towards Treatment of Volumetric Muscle Loss
6 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Walker (United States), The University of Texas at Austin

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago